Invex Therapeutics Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.08; its P/E ratio is -1.00; Invex Therapeutics Ltd. is scheduled to report earnings on August 15, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20
Income Statement	-
Total Revenue	-	-	-
Gross Profit	-	-	-
EBIT	-	-	-
EBITDA	-	-	-
Net Income Common Stockholders	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 29.34M	AU$ 32.72M	AU$ 26.30M
Total Assets	AU$ 29.49M	AU$ 32.74M	AU$ 26.42M
Total Debt	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -29.34M	AU$ -32.72M	AU$ -26.30M
Total Liabilities	AU$ 1.00M	AU$ 658.61K	AU$ 2.02M
Stockholders Equity	AU$ 28.48M	AU$ 32.08M	AU$ 24.40M
Cash Flow	-
Free Cash Flow	-	-	-
Operating Cash Flow	-	-	-
Investing Cash Flow	-	-	-
Financing Cash Flow	-	-	-

Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

Income Statement >

Invex Therapeutics Ltd. Debt to Assets

Balance Sheet >

Invex Therapeutics Ltd. Cash Flow

Cash Flow >

Invex Therapeutics Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing